Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003131585 | SCV003808775 | uncertain significance | MEGF8-related Carpenter syndrome | 2022-12-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004636712 | SCV005131039 | uncertain significance | Inborn genetic diseases | 2024-06-07 | criteria provided, single submitter | clinical testing | The c.320G>A (p.R107Q) alteration is located in exon 2 (coding exon 2) of the MEGF8 gene. This alteration results from a G to A substitution at nucleotide position 320, causing the arginine (R) at amino acid position 107 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |